NanoEntek, Inc. (KOSDAQ:039860)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,540.00
-145.00 (-3.09%)
At close: Feb 20, 2026

NanoEntek Company Description

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers.

The company also provides digital healthcare services integrating artificial intelligence and big data technologies.

The company was founded in 1987 and is headquartered in Seoul, South Korea.

NanoEntek, Inc.
CountrySouth Korea
Founded1987
IndustryLaboratory Analytical Instruments
Employees97
CEOJin-Hyung Park

Contact Details

Address:
5, Digital-ro 26-gil
Seoul, 08389
South Korea
Phone82 2 6220 7728
Websitenanoentek.com

Stock Details

Ticker Symbol039860
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code3826

Key Executives

NamePosition
Jin-Hyung ParkChief Executive Officer